Kliniske data fra et begrænset antal eksponerede gravide (22) indikerer, at der ikke er noget klinisk bevis for, at behandling med Vaniqa ugunstigt påvirker moder eller foster.
Throughout clinical trials data from a limited number of exposed pregnancies (22) indicate that there is no clinical evidence that treatment with Vaniqa adversely affects mothers or foetuses.